Oncology News

Individuals with Lynch syndrome who took resistant starch supplements for at least 2 years developed significantly fewer non-colorectal cancers, results of a 10-year follow-up study in Cancer Prevention Research showed.

Hepatocellular carcinoma surveillance was underutilized in more than 80% of patients with cirrhosis, with lack of clinician orders and lack of patient adherence cited as common screening barriers, according to a study in JAMA Network Open.

Phase 3 studies of pembrolizumab — with chemotherapy for metastatic castration-resistant prostate cancer and with lenvatinib for unresectable liver cancer — did not meet primary endpoints of survival, according to the agent’s manufacturer.

Transcatheter arterial chemoembolization alone and with microwave ablation yielded comparable overall survival rates in patients with recurrent small hepatocellular carcinoma after resection, per research in BMC Gastroenterology.

Most gastrointestinal tract surgeries performed before hospice admission were for urgent or emergent complications of cancer and required patient hospitalization in the preceding 3 years, according to a California-based cohort study.

Early recognition and prompt administration of antibiotics are important factors in managing neutropenic enterocolitis, a common and potentially life-threatening condition that can befall pediatric patients with cancer, a review found.

Artificial intelligence-assisted colonoscopy improved overall adenoma detection rate compared with conventional colonoscopy, according to research published in Clinical Gastroenterology and Hepatology.

The Association of Coloproctology of Great Britain and Ireland and the British Society of Gastroenterology have published a joint guideline for the strategic use of fecal immunochemical testing in people with suspected colorectal cancer.

LONDON — Longitudinal serum alanine aminotransferase trajectories remained stable over time among a subset of patients with nonalcoholic fatty liver disease, according to research presented at the International Liver Congress.

Researchers have discovered geographic patterns of mortality rates among patients with young-onset colorectal cancer in the United States, according to findings published in Gastroenterology.